Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7312 p233
14 August 2004


Society summary


Fees to rise 25pc to secure future

Simpler fee structure agreed

The Society’s Council has approved a simplified structure for members’ retention fees, to be phased in over three years. It reflects the introduction of a two-tier register when continuing professional development becomes mandatory, which is expected to be a provision of pharmacy’s Section 60 Order under the Health Act 1999.

The August Council meeting agreed that there will be just two levels of fee — one for practising pharmacists and one for non-practising pharmacists. The non-practising fee is expected to be maintained at one third of the practising fee. To smooth the transition, the changes to the non-practising fee will be phased in and it will be set at 18 per cent of the practising fee in 2005, 25 per cent in 2006 and 33 per cent in 2007.

The Council’s decision is in line with the responses from members to the consultation on mandatory CPD. Some 8,000 pharmacists responded and 78 per cent agreed that the Society should restructure the register to create practising and non-practising categories for pharmacists. Members acknowledged that a pharmacist could not be eligible to practise without evidence of CPD and accepted that pharmacists in such circumstances should declare that they are non-practising.

As part of a five-year plan to improve the Royal Pharmaceutical Society’s financial security and underpin the development of membership activities, the Council is to ask the Privy Council to agree an increase of £51 (25 per cent) on the members’ retention fee. Most other personal fees would also rise about 25 per cent in 2005.

At the August Council meeting, the Council decided to take action to move towards a firmer financial foundation for the Society’s core activities, to establish healthy reserves and to support the Charter objects of professional leadership, development and representation.

The Society finances its activities both from fee income (some £8.5m) and from the surplus generated by its publications activities. Over the years, the Society’s scope of activity — in membership activity as well as regulation — has grown while the retention fee has failed to keep pace, with the result that it is now among the lowest of the UK health professions. As a result, the contribution from publications has had to subsidise a significant part of the Society’s core work.

The Council agreed that it is not prudent to depend to such a large extent on surplus income from publishing activities, which operate in a risk market. The Council accepted that there was a need to look to the retention fee to provide a secure income base that would underpin all the Society’s core professional and regulatory activities.

The Council decided that over the next five years the retention fee will need to be increased to bring it to a level that can sustain the full scope of the Society’s membership and regulatory activity. For 2005, the Council is to ask for a 25 per cent increase, bringing the retention fee up to £256 from £205. The plan is to move over five years to a position whereby the contribution from publications can be used to boost the Society’s reserves.

The Council was reminded that over recent years the Society’s cash reserves have been drawn on to meet expenditure and the level of their replenishment has depended largely on the year-end financial result. The Council agreed that part of its duty is to safeguard the Society’s long-term financial future by building the reserves back to an appropriate level. A policy would be established to identify and commit to the maintenance of an appropriate level of reserves.

The Council also agreed that a stable funding basis was necessary to support the objects in the revised draft Charter. The Society is already active in programmes to take forward professional development and professional representation. New roles for the branches, work to promote local pharmacy leadership and a review of the impact of devolution are among developments in progress. The Council agreed that it was important for all these areas of activity to enjoy a stable funding base so that programmes could be planned and implemented as a core part of the Society’s work.

The Council further agreed to seek increases in the premises fees, with the retention fee rising 20 per cent from £125 to £150. The initial registration fee for premises would rise substantially from £163 to £460 to reflect the actual costs involved in registering a new pharmacy, based on an inspector spending two days undertaking a review, including initial review of papers, inspecting the premises and following up with the relevant supporting documentation on findings and recommendations.

A Byelaw amendment is published in this week’s Journal (p241). Members have 60 days in which to comment on the proposed amendments.

Back to Top


©The Pharmaceutical Journal